Sp272

DISCONNECTED DUCT SYNDROME: DIAGNOSIS AND MANAGEMENT

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

This session will cover all aspects of acute pancreatitis. LIVE STREAM SESSION

Presenter

Speaker Image for Guru Trikudanathan
University of Minnesota

Tracks

Related Products

Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA
Thumbnail for A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMIS-UC, COHORT 1
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMIS-UC, COHORT 1
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for DELAY IN TRANSFER, LARGER NECROTIC COLLECTION, AND NEED FOR ENTERAL NUTRITION ASSOCIATED WITH INCREASED 30 DAY UNPLANNED READMISSION IN NECROTIZING PANCREATITIS (NP) - A 12 YEAR EXPERIENCE FROM A TERTIARY CARE CENTER
DELAY IN TRANSFER, LARGER NECROTIC COLLECTION, AND NEED FOR ENTERAL NUTRITION ASSOCIATED WITH INCREASED 30 DAY UNPLANNED READMISSION IN NECROTIZING PANCREATITIS (NP) - A 12 YEAR EXPERIENCE FROM A TERTIARY CARE CENTER
Germline genetic testing is recommended for younger patients with idiopathic pancreatitis, but there is no consensus recommendation for those over age 35. We aimed to analyze the results of genetic testing for pancreatic genetic mutations using a large dataset including all ages…